Natera, Inc. - ROE
NTRA
Price:
$231.41
Market Cap:
$33.14B
Natera, Inc. is a diagnostics company focused on developing and commercializing a wide array of molecular testing services globally. Its portfolio includes several key offerings: Panorama, a non-invasive prenatal test (NIPT) that screens for chromosomal abnormalities in a fetus using a blood sample from the mother, and also determines zygosity in twin pregnancies. Vistara, designed to identify single-gene disorders by screening for specific single-gene mutations. Horizon, a comprehensive carrier screening test to determine an individual's carrier status for various genetic diseases. Spectrum, utilized during in vitro fertilization (IVF) cycles to detect chromosomal anomalies or inherited gen...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2015-07-01
Stock Exchange
NASDAQ
Ticker
NTRA
PE Ratio
[-142.85]
ROE
[-15.13%]
Current Ratio
[2.96]
Dividend Yield
[0%]
Enterprise Value
[32.29B]
Dividend History
The ROE as of June 2026 (TTM) for Natera, Inc. (NTRA) is -15.13%
According to Natera, Inc.’s latest financial reports and current stock price. The company's current ROE is -15.13%. This represents a change of 253.25% compared to the average of -4.28% of the last 4 quarters.
Natera, Inc. (NTRA) Historical ROE (quarterly & annually)
How has NTRA ROE performed in the past?
The mean historical ROE of Natera, Inc. over the last ten years is -135.15%. The current -15.13% ROE has changed -88.81% with respect to the historical average. Over the past ten years (40 quarters), NTRA's ROE was at its highest in in the March 2018 quarter at 848.12%. The ROE was at its lowest in in the March 2019 quarter at -683.73%.
Average
-135.15%
Median
-64.51%
Minimum
-536.31%
Maximum
-12.16%
Natera, Inc. (NTRA) ROE by Quarter and Year
Discovering the peaks and valleys of Natera, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 496.29%
Maximum Annual ROE = -12.16%
Minimum Annual Increase = -88.76%
Minimum Annual ROE = -536.31%
| Year | ROE | Change |
|---|---|---|
| 2025 | -12.16% | -23.69% |
| 2024 | -15.93% | -71.96% |
| 2023 | -56.81% | -26.81% |
| 2022 | -77.62% | 7.50% |
| 2021 | -72.20% | 52.82% |
| 2020 | -47.25% | 5.50% |
| 2019 | -44.79% | -88.76% |
| 2018 | -398.46% | -25.70% |
| 2017 | -536.31% | 496.29% |
| 2016 | -89.94% | 136.47% |
Natera, Inc. (NTRA) Average ROE
How has NTRA ROE performed in the past?
The current ROE of Natera, Inc. (NTRA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-28.30%
5-year avg
-46.94%
10-year avg
-135.15%
Natera, Inc. (NTRA) ROE vs. Peers
How is NTRA’s ROE compared to its peers?
Natera, Inc.’s ROE is greater than Mettler-Toledo International Inc. (-610.32%), less than Waters Corporation (8.04%), greater than BioNTech SE (-6.67%), less than Quest Diagnostics Incorporated (14.11%), less than Teva Pharmaceutical Industries Limited (20.79%), less than Koninklijke Philips N.V. (8.96%), less than Illumina, Inc. (33.99%), less than IQVIA Holdings Inc. (22.46%), less than DexCom, Inc. (33.83%), less than STERIS plc (11.05%),
| Company | ROE | Market cap |
|---|---|---|
| -610.32% | $23.13B | |
| 8.04% | $23.17B | |
| -6.67% | $22.98B | |
| 14.11% | $21.59B | |
| 20.79% | $36.66B | |
| 8.96% | $26.01B | |
| 33.99% | $24.50B | |
| 22.46% | $28.00B | |
| 33.83% | $27.96B | |
| 11.05% | $19.75B |
Build a custom stock screener for Natera, Inc. (NTRA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Natera, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Natera, Inc. (NTRA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Natera, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Natera, Inc.'s ROE?
How is the ROE calculated for Natera, Inc. (NTRA)?
What is the highest ROE for Natera, Inc. (NTRA)?
What is the 3-year average ROE for Natera, Inc. (NTRA)?
What is the 5-year average ROE for Natera, Inc. (NTRA)?
How does the current ROE for Natera, Inc. (NTRA) compare to its historical average?